Disconnect between radiographic progression and skin or arthritic outcomes in psoriatic arthritis patients treated with adalimumab - 09/05/15
Philip Mease, Swedish Medical Center and University of Washington, Seattle, WA, United States; Christopher Ritchlin, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States; Simone Rubant, AbbVie Deutschland GmbH & Co KG, Wiesbaden, Germany; Nupun Varothai, AbbVie Inc, North Chicago, IL, United States; Maja Hojnik, AbbVie LLC, Ljubljana, Slovenia; Martin Okun, AbbVie Inc, North Chicago, IL, United States; Alice Gottlieb, Tufts Medical Center, Boston, MA, United States
Le texte complet de cet article est disponible en PDF. The authors and AbbVie scientists designed the study and analyzed and interpreted the data. All authors contributed to the development of the content; all authors and AbbVie reviewed and approved the presentation. |
Vol 72 - N° 5S1
P. AB230 - mai 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?